Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Pharmaceutical Continuous Manufacturing Market (Application - Active Pharmaceutical Ingredient, Biologics, and Dry Powders; End Users) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Published by Transparency Market Research Product code 572227
Published Content info 153 Pages
Delivery time: 1-2 business days
Price
Back to Top
Pharmaceutical Continuous Manufacturing Market (Application - Active Pharmaceutical Ingredient, Biologics, and Dry Powders; End Users) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Published: October 4, 2017 Content info: 153 Pages
Description

Title:
Pharmaceutical Continuous Manufacturing Market (Application - Active Pharmaceutical Ingredient, Biologics, and Dry Powders; End Users - Pharmaceutical Companies and Contract Manufacturing Organization) Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.

Global Pharmaceutical Continuous Manufacturing Technology Market: Overview

This report on pharmaceutical continuous manufacturing technology market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global pharmaceutical continuous manufacturing technology market with respect to the leading market segments based on major products segment, end users, and geographies.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the pharmaceutical continuous manufacturing technology market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global pharmaceutical continuous manufacturing technology market.

Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Pharmaceutical Continuous Manufacturing Technology Market: Segmentation

Based on the application type, the pharmaceutical continuous manufacturing technology market has been segmented into: active pharmaceutical ingredient, biologics, dry powders & others. In term of end-users products divided into pharmaceutical companies, contract manufacturing organizations and others. Each of the market segments have been extensively analyzed based on the market related factors such as increasing awareness worldwide, technological advancement, and growing number of user in various geographies.

Geographically, pharmaceutical continuous manufacturing technology market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Rest of World. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions.

Global Pharmaceutical Continuous Manufacturing Technology Market: Competitive Analysis

A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter's five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global pharmaceutical continuous manufacturing technology market.

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global pharmaceutical continuous manufacturing technology market. The report also profiles key players operating in the pharmaceutical continuous manufacturing technology market which are Siemens AG, GEA group, Continuus Pharmaceutical, S K Biotek ltd, Korsch AG, Scott Equipment Company, Corning Life Sciences, Chemtrix, Ehrfeld etc.

The global pharmaceutical continuous manufacturing technology market is segmented as follows:

Global Pharmaceutical continuous manufacturing technology Market, by Application Type

  • Active Pharmaceutical ingredient
  • Biologics
  • Dry Powders
  • Others

Global Pharmaceutical continuous manufacturing technology Market, by End-users

  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Others

Global Pharmaceutical continuous manufacturing technology Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of the Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
Table of Contents

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Acronyms Used
  • 2.3. Research Methodology

3. Executive Summary

  • 3.1. Global Pharmaceutical Continuous Manufacturing Technology Market Snapshot

4. Market Overview

  • 4.1. Product Overview
  • 4.2. Market Opportunity Map
  • 4.3. Key Industry Events
  • 4.4. Global Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, 2015-2025
  • 4.5. Global Pharmaceutical Continuous Manufacturing Technology Market Outlook
  • 4.6. Porter's Five Forces Analysis

5. Market Dynamics

  • 5.1. Drivers and Restraints Snapshot Analysis
  • 5.2. Drivers
    • 5.2.1. Increased inefficiency in the manufacturing process
    • 5.2.2. Safer production
    • 5.2.3. Advantages over the batch manufacturing
    • 5.2.4. Increased FDA initiatives
  • 5.3. Restraints
    • 5.3.1. Regulatory challenges
    • 5.3.2. Difficulties in adoption
  • 5.4. Opportunities
    • 5.4.1. Improving Pharma Infrastructure
  • 5.5. Global API Manufacturing Technology Suppliers Market Share Analysis, by Company, 2016 (estimated)

6. Global Pharmaceutical Continuous Manufacturing Technology Market, by Application

  • 6.1. Introduction
  • 6.2. Key Findings
  • 6.3. Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
  • 6.4. Global Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
  • 6.5. Global Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
  • 6.6. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by Application
  • 6.7. Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application
  • 6.8. Key Trends

7. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by End-user

  • 7.1. Introduction
  • 7.2. Key Findings
  • 7.3. Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
  • 7.4. Global Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
  • 7.5. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by End-user
  • 7.6. Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user
  • 7.7. Key Trends

8. Global Pharmaceutical Continuous Manufacturing Technology Market Analysis, by Region

  • 8.1. Global Market Scenario, by Country
  • 8.2. Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Region
  • 8.3. Global Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Region, 2015-2025
  • 8.4. Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Region

9. North America Pharmaceutical Continuous Manufacturing Technology Market Analysis

  • 9.1. Key Findings
  • 9.2. North America Pharmaceutical Continuous Manufacturing Technology Market Overview
  • 9.3. North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
  • 9.4. North America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
  • 9.5. North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
  • 9.6. North America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
  • 9.7. North America Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
  • 9.8. North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
  • 9.9. North America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
  • 9.10. North America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
  • 9.11. Key Trends

10. Europe Pharmaceutical Continuous Manufacturing Technology Market Analysis

  • 10.1. Key Findings
  • 10.2. Europe Pharmaceutical Continuous Manufacturing Technology Market Overview
  • 10.3. Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
  • 10.4. Europe Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
  • 10.5. Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
  • 10.6. Europe Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
  • 10.7. Europe Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
  • 10.8. Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
  • 10.9. Europe Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
  • 10.10. Europe Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
  • 10.11. Key Trends

11. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Analysis

  • 11.1. Key Findings
  • 11.2. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Overview
  • 11.3. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
  • 11.4. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
  • 11.5. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
  • 11.6. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
  • 11.7. Asia Pacific Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
  • 11.8. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
  • 11.9. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
  • 11.10. Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis
  • 11.11. Key Trends

12. Latin America Pharmaceutical Continuous Manufacturing Technology Market Analysis

  • 12.1. Key Findings
  • 12.2. Latin America Pharmaceutical Continuous Manufacturing Technology Market Overview
  • 12.3. Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
  • 12.4. Latin America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
  • 12.5. Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
  • 12.6. Latin America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
  • 12.7. Latin America Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
  • 12.8. Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
  • 12.9. Latin America Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
  • 12.10. Latin America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis

13. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Analysis

  • 13.1. Key Findings
  • 13.2. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Overview
  • 13.3. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country
  • 13.4. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Country
  • 13.5. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application
  • 13.6. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Forecast, by Application
  • 13.7. Middle East & Africa Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user
  • 13.8. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user
  • 13.9. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Forecast, by End-user
  • 13.10. Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis

14. Competition Landscape

  • 14.1. Competition Matrix
  • 14.2. Company Profiles
    • 14.2.1. Siemens AG
      • 14.2.1.1. Company Details
      • 14.2.1.2. Business Overview
      • 14.2.1.3. Financial Overview
      • 14.2.1.4. Strategic Overview
      • 14.2.1.5. SWOT Analysis
    • 14.2.2. GEA Group
      • 14.2.2.1. Company Details
      • 14.2.2.2. Business Overview
      • 14.2.2.3. Financial Overview
      • 14.2.2.4. Strategic Overview
      • 14.2.2.5. SWOT Analysis
    • 14.2.3. SK biotek Co., Ltd.
      • 14.2.3.1. Company Details
      • 14.2.3.2. Business Overview
      • 14.2.3.3. Financial Overview
      • 14.2.3.4. Strategic Overview
      • 14.2.3.5. SWOT Analysis
    • 14.2.4. CONTINUUS Pharmaceuticals
      • 14.2.4.1. Company Details
      • 14.2.4.2. Business Overview
      • 14.2.4.3. Financial Overview
      • 14.2.4.4. Strategic Overview
      • 14.2.4.5. SWOT Analysis
    • 14.2.5. Gebruder Lodige Maschinenbau GmbH
      • 14.2.5.1. Company Details
      • 14.2.5.2. Business Overview
      • 14.2.5.3. Financial Overview
      • 14.2.5.4. Strategic Overview
      • 14.2.5.5. SWOT Analysis
    • 14.2.6. Glatt GmbH
      • 14.2.6.1. Company Details
      • 14.2.6.2. Business Overview
      • 14.2.6.3. Financial Overview
      • 14.2.6.4. Strategic Overview
      • 14.2.6.5. SWOT Analysis
    • 14.2.7. KORSCH AG
      • 14.2.7.1. Company Details
      • 14.2.7.2. Business Overview
      • 14.2.7.3. Financial Overview
      • 14.2.7.4. Strategic Overview
      • 14.2.7.5. SWOT Analysis
    • 14.2.8. Scott Equipment Company
      • 14.2.8.1. Company Details
      • 14.2.8.2. Business Overview
      • 14.2.8.3. Financial Overview
      • 14.2.8.4. Strategic Overview
      • 14.2.8.5. SWOT Analysis
    • 14.2.9. Thermo Fisher Scientific, Inc.
      • 14.2.9.1. Company Details
      • 14.2.9.2. Business Overview
      • 14.2.9.3. Financial Overview
      • 14.2.9.4. Strategic Overview
      • 14.2.9.5. SWOT Analysis
    • 14.2.10. L.B. Bohle Maschinen + Verfahren Gmbh
      • 14.2.10.1. Company Details
      • 14.2.10.2. Business Overview
      • 14.2.10.3. Financial Overview
      • 14.2.10.4. Strategic Overview
      • 14.2.10.5. SWOT Analysis
    • 14.2.11. Munson Machinery Company
      • 14.2.11.1. Company Details
      • 14.2.11.2. Business Overview
      • 14.2.11.3. Financial Overview
      • 14.2.11.4. Strategic Overview
      • 14.2.11.5. SWOT Analysis

List of Tables

  • TABLE 1 Revenue Share by Application
  • TABLE 2 Revenue Share by End-user
  • TABLE 3 Global Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • TABLE 4 Global Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 5 Global Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 6 Global Pharmaceutical Continuous Manufacturing Technology Market Revenue (US$ Mn) Forecast, by Region, 2015-2025
  • TABLE 7 North America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • TABLE 8 North America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • TABLE 9 North America Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 10 North America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 11 Europe Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • TABLE 12 Europe Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • TABLE 13 Europe Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 14 Europe Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 15 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • TABLE 16 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • TABLE 17 Asia Pacific Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 18 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 19 Latin America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • TABLE 20 Latin America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • TABLE 21 Latin America Pharmaceutical API Continuous Manufacturing Technology Forecast, by End-user, 2015-2025
  • TABLE 22 Latin America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 23 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • TABLE 24 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • TABLE 25 Middle East & Africa Pharmaceutical API Continuous Manufacturing Technology (US$ Mn) Forecast, by End-user, 2015-2025
  • TABLE 26 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, by End-user, 2015-2025

List of Figures

  • FIG. 1 Global Market Size (US$ Mn), by Application, 2016
  • FIG. 2 Global Market Size (US$ Mn), by End-users, 2016
  • FIG. 3 Key Trends in Continuous Manufacturing Technology
  • FIG. 4 Global Market share, by Region, 2016
  • FIG. 5 Key Industry Developments
  • FIG. 6 Global Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) Forecast, 2015-2025
  • FIG. 7 Market Value Share, by End-user (2016)
  • FIG. 8 Market Value Share, by Application (2016)
  • FIG. 9 Market Value Share, by Region (2016)
  • FIG. 10 Addressable Pharmaceutical Manufacturing Market
  • FIG. 11 Global API Manufacturing Technology Suppliers Market Share Analysis, by Company, 2016
  • FIG. 12 Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application, 2016 and 2025
  • FIG. 13 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth, by Active Pharmaceutical Ingredients (API), 2015-2025
  • FIG. 14 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth, by Biologics, 2015-2025
  • FIG. 15 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth, by Dry Powder, 2015-2025
  • FIG. 16 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2015-2025
  • FIG. 17 Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application, 2015-2025
  • FIG. 18 Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user, 2016 and 2025
  • FIG. 19 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pharmaceutical Companies, 2015-2025
  • FIG. 20 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contract Manufacturing Organizations, 2015-2025
  • FIG. 21 Global Pharmaceutical Continuous Manufacturing Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015-2025
  • FIG. 22 Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user,2017-2025
  • FIG. 23 Global Market Scenario, by country
  • FIG. 24 Global Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Region, 2016 and 2025
  • FIG. 25 Global Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Region, 2017-2025
  • FIG. 26 North America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • FIG. 27 North America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Country, 2017-2025
  • FIG. 28 North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country, 2016 and 2025
  • FIG. 29 North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application, 2016 and 2025
  • FIG. 30 North America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user, 2016 and 2025
  • FIG. 31 North America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application, 2017-2025
  • FIG. 32 North America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user, 2017-2025
  • FIG. 33 Europe Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • FIG. 34 Europe Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Country, 2017-2025
  • FIG. 35 Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country, 2016 and 2025
  • FIG. 36 Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application, 2016 and 2025
  • FIG. 37 Europe Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user, 2016 and 2025
  • FIG. 38 Europe Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application, 2015-2025
  • FIG. 39 Europe Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user, 2015-2025
  • FIG. 40 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • FIG. 41 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Country, 2017-2025
  • FIG. 42 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country, 2016 and 2025
  • FIG. 43 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application, 2016 and 2025
  • FIG. 44 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user, 2016 and 2025
  • FIG. 45 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application, 2015-2025
  • FIG. 46 Asia Pacific Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user, 2015-2025
  • FIG. 47 Latin America Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • FIG. 48 Latin America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Country, 2017-2025
  • FIG. 49 Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country, 2016 and 2025
  • FIG. 50 Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application, 2016 and 2025
  • FIG. 51 Latin America Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user, 2016 and 2025
  • FIG. 52 Latin America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application, 2017-2025
  • FIG. 53 Latin America Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user, 2017-2025
  • FIG. 54 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • FIG. 55 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Country, 2017-2025
  • FIG. 56 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Country, 2016 and 2025
  • FIG. 57 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by Application, 2016 and 2025
  • FIG. 58 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Value Share Analysis, by End-user, 2016 and 2025
  • FIG. 59 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by Application, 2017-2025
  • FIG. 60 Middle East & Africa Pharmaceutical Continuous Manufacturing Technology Market Attractiveness Analysis, by End-user, 2017-2025
  • FIG. 61 Siemens AG Breakdown of Net Sales, by Business Segment, 2016
  • FIG. 62 Siemens AG Total Revenue (US$ Bn) and Y-o-Y Growth (%), 2014-2016
  • FIG. 63 GEA Breakdown of Net Sales, by Business Segment, 2016
  • FIG. 64 GEA Revenue for (US$ Bn) and Y-o-Y Growth (%), 2014-2016
  • FIG. 65 SK biotek co. ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2016
  • FIG. 66 Thermo Fischer Scientific, Inc Breakdown of Net Sales, by Region, 2016
  • FIG. 67 Thermo Fischer Scientific, Inc Revenue (US$ Bn) and Y-o-Y Growth (%), 2013-2016
Back to Top